Trials / Terminated
TerminatedNCT06230393
An Extension Trial for Patients With Open-Angle Glaucoma Who Participated in the DF6-CL-20-01 Protocol.
An Extension Trial to Evaluate the Long Term Safety and Effectiveness of the STREAMLINE® SURGICAL SYSTEM in Patients With Open-Angle Glaucoma Who Participated in the DF6-CL-20-01 Protocol.
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 17 (actual)
- Sponsor
- New World Medical, Inc. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
The purpose of this study is to evaluate long term safety and effectiveness of the STREAMLINE® SURGICAL SYSTEM
Detailed description
A Retrospective, nonrandomized, open-label study to evaluate the long term safety and IOP-lowering effectiveness of STREAMLINE® SURGICAL SYSTEM in patients with open-angle glaucoma who participated in the DF6-CL-20-01 protocol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | STREAMLINE® SURGICAL SYSTEM | STREAMLINE® SURGICAL SYSTEM |
Timeline
- Start date
- 2024-06-01
- Primary completion
- 2025-12-04
- Completion
- 2025-12-04
- First posted
- 2024-01-30
- Last updated
- 2026-03-30
Locations
1 site across 1 country: Costa Rica
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06230393. Inclusion in this directory is not an endorsement.